Kwong, P. D. & Mascola, J. R. HIV-1 vaccines based on antibody identification, B cell ontogeny, and epitope structure. Immunity 48, 855–871 (2018).

Article  CAS  PubMed  Google Scholar 

McCoy, L. E. The expanding array of HIV broadly neutralizing antibodies. Retrovirology 15, 70 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sok, D. & Burton, D. R. Recent progress in broadly neutralizing antibodies to HIV. Nat. Immunol. 19, 1179–1188 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Del Moral-Sánchez, I. & Sliepen, K. Strategies for inducing effective neutralizing antibody responses against HIV-1. Expert Rev. Vaccines 18, 1127–1143 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Williams, W. B., Wiehe, K., Saunders, K. O. & Haynes, B. F. Strategies for induction of HIV-1 envelope-reactive broadly neutralizing antibodies. J. Int. AIDS Soc. 24, e25831 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Derking, R. & Sanders, R. W. Structure-guided envelope trimer design in HIV-1 vaccine development: a narrative review. J. Int. AIDS Soc. 24, e25797 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Moldt, B. et al. Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo. Proc. Natl. Acad. Sci. USA 109, 18921–18925 (2012).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shingai, M. et al. Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques. J. Exp. Med. 211, 2061–2074 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gautam, R. et al. A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges. Nature 533, 105–109 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Feng, Y., Broder, C. C., Kennedy, P. E. & Berger, E. A. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272, 872–877 (1996).

Article  CAS  PubMed  Google Scholar 

Maddon, P. J. et al. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47, 333–348 (1986).

Article  CAS  PubMed  Google Scholar 

Sanders, R. W. & Moore, J. P. HIV: a stamp on the envelope. Nature 514, 437–438 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

McDougal, J. S. et al. Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule. Science 231, 382–385 (1986).

Article  CAS  PubMed  Google Scholar 

Moore, J. P., Trkola, A. & Dragic, T. Co-receptors for HIV-1 entry. Curr. Opin. Immunol. 9, 551–562 (1997).

Article  CAS  PubMed  Google Scholar 

McCune, J. M. et al. Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus. Cell 53, 55–67 (1988).

Article  CAS  PubMed  Google Scholar 

Moulard, M. & Decroly, E. Maturation of HIV envelope glycoprotein precursors by cellular endoproteases. Biochim. Biophys. Acta 1469, 121–132 (2000).

Article  CAS  PubMed  Google Scholar 

Poignard, P., Saphire, E. O., Parren, P. W. & Burton, D. R. gp120: biologic aspects of structural features. Annu. Rev. Immunol. 19, 253–274 (2001).

Article  CAS  PubMed  Google Scholar 

Willey, R. L., Bonifacino, J. S., Potts, B. J., Martin, M. A. & Klausner, R. D. Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160. Proc. Natl. Acad. Sci. USA 85, 9580–9584 (1988).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moore, J. P., McKeating, J. A., Weiss, R. A. & Sattentau, Q. J. Dissociation of gp120 from HIV-1 virions induced by soluble CD4. Science 250, 1139–1142 (1990).

Article  CAS  PubMed  Google Scholar 

Chakrabarti, B. K. et al. HIV type 1 Env precursor cleavage state affects recognition by both neutralizing and nonneutralizing gp41 antibodies. AIDS Res. Hum. Retroviruses 27, 877–887 (2011).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sliepen, K. & Sanders, R. W. HIV-1 envelope glycoprotein immunogens to induce broadly neutralizing antibodies. Expert Rev. Vaccines 15, 349–365 (2016).

Article  CAS  PubMed  Google Scholar 

Sanders, R. W. et al. HIV-1 VACCINES. HIV-1 neutralizing antibodies induced by native-like envelope trimers. Science 349, aac4223 (2015).

Article  PubMed  PubMed Central  Google Scholar 

Kovacs, J. M. et al. HIV-1 envelope trimer elicits more potent neutralizing antibody responses than monomeric gp120. Proc. Natl. Acad. Sci. USA 109, 12111–12116 (2012).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Julien, J.-P. et al. Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9. Proc. Natl. Acad. Sci. USA 110, 4351–4356 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hoffenberg, S. et al. Identification of an HIV-1 clade A envelope that exhibits broad antigenicity and neutralization sensitivity and elicits antibodies targeting three distinct epitopes. J. Virol. 87, 5372–5383 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Davenport, T. M. et al. Binding interactions between soluble HIV envelope glycoproteins and quaternary-structure-specific monoclonal antibodies PG9 and PG16. J. Virol. 85, 7095–7107 (2011).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Binley, J. M. et al. A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure. J. Virol. 74, 627–643 (2000).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Binley, J. M. et al. Enhancing the proteolytic maturation of human immunodeficiency virus type 1 envelope glycoproteins. J. Virol. 76, 2606–2616 (2002).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sanders, R. W. et al. Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1. J. Virol. 76, 8875–8889 (2002).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sanders, R. W. et al. A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies. PLoS Pathog. 9, e1003618 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sanders, R. W. & Moore, J. P. Virus vaccines: proteins prefer prolines. Cell Host Microbe 29, 327–333 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ringe, R. P. et al. Cleavage strongly influences whether soluble HIV-1 envelope glycoprotein trimers adopt a native-like conformation. Proc. Natl. Acad. Sci. USA 110, 18256–18261 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Julien, J.-P. et al. Crystal structure of a soluble cleaved HIV-1 envelope trimer. Science 342, 1477–1483 (2013).

Article  CAS  PubMed  Google Scholar 

Lyumkis, D. et al. Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer. Science 342, 1484–1490 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Georgiev, I. S. et al. Single-chain soluble BG505.SOSIP gp140 trimers as structural and antigenic mimics of mature closed HIV-1 Env. J. Virol. 89, 5318–5329 (2015).

Article  CAS